Press Release
Oct 09, 2017
Award supports innovative research for early lung cancer detection
DENVER, CO - Free ME From Lung Cancer (FMFLC) and the International Association for the Study of Lung Cancer (IASLC) today announced the first ever $200,000 FMFLC-IASLC Joint Fellowship Award for the Early Detection of Lung Cancer. The FMFLC-IASLC Joint Fellowship Award supports novel, innovative and translational research with the potential of having a high clinical impact on the early detection of lung cancer.
“This first joint award between FMFLC and the IASLC funds research that will positively impact lung cancer patients,” said Deb Violette, President and Founder of FMFLC. “We are thrilled to be working with the IASLC to help change the lives of lung cancer patients.”
The objective of this new FMFLC-IASLC award is fund research that will deliver a meaningful and measurable result for the early detection of lung cancer and that has a high probability of near-term benefit to lung cancer patients or individuals at risk.
The FMFLC-IASLC Joint Fellowship Award for the Early Detection of Lung Cancer is a two year award, $100,000 per year (totaling $200,000). Applications will be accepted until December 31, 2017. The award winner will be notified on March 15, 2018. For more information about the award, please view this website.
“We are very excited to be partnering with FMFLC and Deb Violette,” said IASLC Foundation Director, AnnMarie Estrada. “Fellowships like this foster groundbreaking and collaborative research worldwide.”
About Free ME From Lung Cancer
Free ME from Lung Cancer is the only nonprofit based in Maine dedicated solely to raising money for lung cancer research, early lung cancer screening for high risk patients who do not have insurance and provide radon air abatement systems to single family low income homeowners.
About International Association for the Study of Lung Cancer
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 6,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information and follow us on Twitter @IASLC.
The IASLC Foundation is the funding source for Research Fellowships, Young Investigator Awards and the Cancer Care Award. The Foundation supports researchers, rewards scientific excellence and encourages innovative research in lung cancer prevention, treatment and cure. For more information about the Foundation and to make a donation visit www.iaslc.org/foundation.